4
Changes in Ownership
Royalty Pharma plc Filed Acc 0001802768-23-000030
Director acquired 475,590 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RIGGS RORY B Director | 2023-11-13 | Conversion | +475,590 | 490,099 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| RIGGS RORY B Director | 2023-11-13 | Conversion · LP interests in RPI US Partners 2019, LP | −47,559 | 300,000 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1700000224.xml…